The Journal of Organic Chemistry
Article
(d, J = 8.2 Hz, 1H), 5.05 (d, J = 4.5 Hz, 1H), 4.76 (d, J = 14.5 Hz,
1H), 4.65 (d, J = 4.5 Hz, 1H), 4.09 (d, J = 14.5 Hz, 1H), 3.78 (s, 3H),
3.62 (s, 3H), 3.12 (s, 3H); 13C{1H} NMR (100 MHz, CDCl3): δ
167.5, 157.6, 157.5, 130.4, 129.3, 128.9, 128.3, 123.5, 122.8, 120.6,
120.5, 110.23, 110.17, 85.8, 58.3, 56.2, 55.4, 55.0, 39.5; HRMS (ESI)
m/z calcd for C19H21NNaO4 [M + Na]+: 350.1368, found: 350.1366.
( )-cis-3-Methoxy-1-(3-methoxybenzyl)-4-(3-methoxyphenyl)-
azetidin-2-one (5e). Yellow oil, 321.0 mg, 65%; 1H NMR (400 MHz,
CDCl3): δ 7.28 (t, J = 8.0 Hz, 1H), 7.20 (t, J = 7.7 Hz, 1H), 6.90−
6.87 (m, 2H), 6.82−6.79 (m, 2H), 6.71 (d, J = 7.7 Hz, 1H), 6.66 (t, J
= 1.8 Hz, 1H), 4.78 (d, J = 14.5 Hz, 1H), 4.66 (d, J = 4.1 Hz, 1H),
4.56 (d, J = 4.1 Hz, 1H), 3.83 (d, J = 15.0 Hz, 1H), 3.78 (s, 3H), 3.75
(s, 3H), 3.13 (s, 3H); 13C{1H} NMR (100 MHz, CDCl3): δ 166.8,
160.0, 159.8, 136.5, 135.2, 129.9, 129.5, 120.9 (overlapped), 114.2,
114.1, 113.9, 113.6, 85.9, 61.2, 58.3, 55.33, 55.29, 44.1; HRMS (ESI)
m/z calcd for C19H21NNaO4 [M + Na]+: 350.1368, found: 350.1366.
( )-cis-3-Methoxy-1-(4-methoxybenzyl)-4-(4-methoxyphenyl)-
the synthesis of various potential drug candidates and
functional molecules. Furthermore, our protocol was extended
to the gram scale and diastereoselective synthesis of β-amino
acids was successfully achieved via hydrolysis of the β-lactam
derivatives constructed by our protocol. The reactions
demonstrated, herein, highlight the importance and conven-
ience of β-lactam derivatives as synthetic intermediates in
chemical and pharmaceutical fields.
EXPERIMENTAL SECTION
■
General Remarks. Unless otherwise stated, all starting materials
and catalysts were purchased from commercial sources and used
without further purification. All solvents were distilled and degassed
with nitrogen before use. The 4.7 wt % 4,6-dihydroxysalicylic acid 2
on a silica gel was synthesized by a previously reported method.49 1H
NMR spectra were recorded on a JEOL JNM-ECS400 (400 MHz)
FT NMR system or a JEOL JNM-ECX400 (400 MHz) FT NMR
system in CDCl3 with Me4Si as an internal standard.13C NMR spectra
were recorded on a JEOL JNM-ECX400 (100 MHz) FT NMR or a
JEOL JNM-ECS400 (100 MHz) FT NMR in CDCl3. High-resolution
mass spectroscopy (HRMS) was conducted on a Bruker micrOTOF
II ESI/TOF analyzer or Waters Synapt G2 HDMS.
1
azetidin-2-one (5f). Colorless oil, 326.2 mg, 66%; H NMR (400
MHz, CDCl3): δ 7.23−7.19 (m, 2H), 7.05-7.02 (m, 2H), 6.92−6.88
(m, 2H), 6.83-6.80 (m, 2H), 4.73 (d, J = 15.0 Hz, 1H), 4.60 (d, J =
4.5 Hz, 1H), 4.49 (d, J = 4.5 Hz, 1H), 3.82 (s, 3H), 3.78 (s, 3H), 3.74
(d, J = 14.5 Hz, 1H), 3.11 (s, 3H); 13C{1H} NMR (100 MHz,
CDCl3): δ 166.8, 159.9, 159.3, 130.0, 129.8, 127.1, 125.3, 114.2,
113.9, 85.7, 60.4, 58.2, 55.3 (overlapped), 43.2; HRMS (ESI) m/z
calcd for C19H21NNaO4 [M + Na]+: 350.1368, found: 350.1375.
General Procedure for the Synthesis of β-Lactams via
Homocoupling of Amines (Table 2). Benzylamines 1 (3.0 mmol),
2,4,6-trihydroxybenzoic acid monohydrate (28.2 mg, 0.15 mmol, 5
mol %), and toluene (1.5 mL) were added to a 20 mL two-neck flask
equipped with an O2 balloon at room temperature and stirred at 90
°C in an oil bath under an O2 atmosphere for 2 h. Then, the O2
balloon was removed and the reaction mixture was cooled to room
temperature. To the reaction mixture, 4A MS (300 mg) and Et3N
(627 μL, 4.5 mmol, 1.5 equiv) were added, and acyl chloride 4 (4.5
mmol, 1.5 equiv) in CH3CN (3.0 mL) was added dropwise at 0 °C.
The resulting solution was stirred at 25 °C for 18 h under a N2
atmosphere. After the reaction was finished, the resulting mixture was
filtered and the filtrate was extracted with AcOMe (10 mL). The
organic layer was washed with H2O (10 mL × 2) and brine (10 mL)
and dried with anhydrous Na2SO4. The solvent was concentrated
under reduced pressure. Finally, the residue was purified by silica-gel
chromatography (AcOMe/iso-hexane) and gel permeation chroma-
tography (eluent: CH2Cl2) to give product 5.
(
)-cis-3-Methoxy-4-(naphthalen-1-yl)-1-(naphthalen-1-
ylmethyl)azetidin-2-one (5g). Light yellow solid, 206.6 mg, 38%, mp
125.2−126.0 °C; 1H NMR (400 MHz, CDCl3): δ 8.13-8.09 (m, 1H),
7.89-7.84 (m, 3H), 7.76 (d, J = 8.2 Hz, 1H), 7.63 (dd, J = 11.4, 7.8
Hz, 2H), 7.55 (d, J = 7.8 Hz, 1H), 7.52−7.48 (m, 2H), 7.46 (dd, J =
8.0, 1.1 Hz, 1H), 7.41−7.37 (m, 1H), 7.20 (dd, J = 8.1, 7.0 Hz, 1H),
7.07 (d, J = 6.4 Hz, 1H), 5.51 (d, J = 14.7 Hz, 1H), 5.13 (d, J = 4.6
Hz, 1H), 4.72 (d, J = 4.6 Hz, 1H), 4.40 (d, J = 14.7 Hz, 1H), 2.95 (s,
3H); 13C{1H} NMR (100 MHz, CDCl3): δ 167.0, 134.0, 133.8,
131.5, 131.4, 130.4, 129.5, 129.2, 129.1, 128.9, 128.8, 128.4, 127.1,
126.4, 126.3, 125.8, 125.44, 125.35, 125.2, 123.6, 122.2, 86.3, 58.9,
57.6, 42.4; HRMS (ESI) m/z calcd for C25H21NNaO2 [M + Na]+:
390.1470, found: 390.1475.
( )-cis-3-Methoxy-4-(thiophen-2-yl)-1-(thiophen-2-ylmethyl)-
1
azetidin-2-one (5h). Yellow oil, 51.6 mg, 12%; H NMR (400 MHz,
CDCl3): δ 7.39 (dd, J = 5.0, 0.9 Hz, 1H), 7.24 (dd, J = 5.0, 1.4 Hz,
1H), 7.09−7.07 (m, 1H), 7.05 (dd, J = 5.0, 3.6 Hz, 1H), 6.94 (dd, J =
5.2, 3.4 Hz, 1H), 6.85 (d, J = 3.2 Hz, 1H), 4.96 (d, J = 4.5 Hz, 1H),
4.92 (d, J = 15.4 Hz, 1H), 4.68 (d, J = 4.1 Hz, 1H), 4.10 (d, J = 15.4
Hz, 1H), 3.25 (s, 3H); 13C{1H} NMR (100 MHz, CDCl3): δ 165.8,
137.0, 136.4, 128.1, 127.4, 127.23, 127.18, 126.9, 126.0, 85.8, 58.6,
56.7, 38.0; HRMS (ESI) m/z calcd for C13H13NNaO2S2 [M + Na]+:
302.0285, found: 302.0300.
( )-cis-1-Benzyl-3-methoxy-4-phenylazetidin-2-one (5a).48 Col-
orless oil, 286.5 mg, 72%; 1H NMR (400 MHz, CDCl3) δ 7.39−7.34
(m, 3H), 7.30−7.26 (m, 5H), 7.12 (m, 2H), 4.82 (d, J = 14.7 Hz,
1H), 4.66 (d, J = 4.6 Hz, 1H), 4.56 (d, J = 4.6 Hz, 1H), 3.81 (d, J =
15.1 Hz, 1H), 3.09 (s, 3H); 13C{1H} NMR (100 MHz, CDCl3): δ
166.9, 135.0, 133.5, 128.9, 128.70, 128.69, 128.6, 128.5, 127.9, 85.9,
61.1, 58.2, 44.0.
( )-cis-1-Benzyl-2-oxo-4-phenylazetidin-3-yl acetate (5i).58 Col-
orless oil, 242.1 mg, 55%; 1H NMR (400 MHz, CDCl3): δ 7.36−7.34
(m, 3H), 7.31−7.28 (m, 3H), 7.21 (dd, J = 7.1, 3.0 Hz, 2H), 7.14 (dd,
J = 7.1, 2.1 Hz, 2H), 5.77 (d, J = 4.6 Hz, 1H), 4.88 (d, J = 14.7 Hz,
1H), 4.75 (d, J = 4.6 Hz, 1H), 3.91 (d, J = 14.7 Hz, 1H), 1.65 (s, 3H);
13C{1H} NMR (100 MHz, CDCl3): δ 169.2, 164.8, 134.5, 132.5,
( )-cis-1-(4-(tert-Butyl)benzyl)-4-(4-(tert-butyl)phenyl)-3-me-
thoxyazetidin-2-one (5b). Yellow oil, 149.1 mg, 26%; 1H NMR (400
MHz, CDCl3): δ 7.40−7.36 (m, 2H), 7.32−7.29 (m, 2H), 7.23−7.20
(m, 2H), 7.08−7.06 (m, 2H), 4.79 (d, J = 14.5 Hz, 1H), 4.64 (d, J =
4.5 Hz, 1H), 4.58 (d, J = 4.5 Hz, 1H), 3.78 (d, J = 15.0 Hz, 1H), 3.12
(s, 3H), 1.33 (s, 9H), 1.30 (s, 9H); 13C{1H} NMR (100 MHz,
CDCl3): δ 167.0, 151.6, 150.8, 132.2, 130.4, 128.4, 128.3, 125.7,
125.4, 85.8, 60.8, 58.3, 43.5, 34.7, 34.6, 31.42, 31.41; HRMS (ESI) m/
z calcd for C25H33NNaO2 [M + Na]+: 402.2409, found: 402.2408.
( )-cis-3-Methoxy-1-(4-methylbenzyl)-4-(p-tolyl)azetidin-2-one
129.0, 128.9, 128.6, 128.5, 128.4, 128.2, 77.5, 61.0, 44.6, 19.9.
( )-cis-1-Benzyl-3-phenoxy-4-phenylazetidin-2-one (5j).48 White
solid, 209.0 mg, 42%; 1H NMR (400 MHz, CDCl3): δ 7.33−7.26 (m,
8H), 7.17−7.15 (m, 2H), 7.11−7.06 (m, 2H), 6.86−6.82 (m, 1H),
6.71−6.69 (m, 2H), 5.39 (d, J = 4.6 Hz, 1H), 4.89 (d, J = 14.7 Hz,
1H), 4.75 (d, J = 4.6 Hz, 1H), 3.86 (d, J = 14.7 Hz, 1H); 13C{1H}
NMR (100 MHz, CDCl3): δ 165.7, 157.0, 134.8, 132.8, 129.3, 129.0,
128.80, 128.77, 128.4, 128.1, 122.1, 115.6, 114.8, 82.2, 61.5, 44.3.
( )-cis-1-Benzyl-3-(4-chlorophenoxy)-4-phenylazetidin-2-one
(5k). White solid, 333.4 mg, 61%, mp 125.8−126.5 °C; 1H NMR (400
MHz, CDCl3): δ 7.33−7.23 (m, 8H), 7.16−7.14 (m, 2H), 7.06−7.02
(m, 2H), 6.66−6.62 (m, 2H), 5.34 (d, J = 4.5 Hz, 1H), 4.89 (d, J =
15.0 Hz, 1H), 4.74 (d, J = 4.5 Hz, 1H), 3.87 (d, J = 15.0 Hz, 1H);
13C{1H} NMR (100 MHz, CDCl3): δ 165.3, 155.5, 134.7, 132.5,
1
(5c). White solid, 271.4 mg, 61%, mp 63.2−64.0 °C; H NMR (400
MHz, CDCl3): δ 7.18 (s, 4H), 7.10 (d, J = 7.8 Hz, 2H), 7.01 (d, J =
8.2 Hz, 2H), 4.80 (d, J = 14.7 Hz, 1H), 4.61 (d, J = 4.1 Hz, 1H), 4.51
(d, J = 4.6 Hz, 1H), 3.73 (d, J = 14.7 Hz, 1H), 3.11 (s, 3H), 2.37 (s,
3H), 2.32 (s, 3H); 13C{1H} NMR (100 MHz, CDCl3): δ 166.9,
138.5, 137.6, 132.0, 130.4, 129.5, 129.3, 128.6, 128.5, 85.8, 60.7, 58.2,
43.5, 21.3, 21.2; HRMS (ESI) m/z calcd for C19H21NNaO2 [M +
Na]+: 318.1470, found: 318.1473.
( )-cis-3-Methoxy-1-(2-methoxybenzyl)-4-(2-methoxyphenyl)-
azetidin-2-one (5d). Yellow solid, 51.3 mg, 10%, mp 98.0−99.0 °C;
1H NMR (400 MHz, CDCl3): δ 7.30−7.22 (m, 3H), 7.14 (dd, J = 7.5,
1.6 Hz, 1H), 6.98 (t, J = 7.5 Hz, 1H), 6.87 (t, J = 7.2 Hz, 2H), 6.78
129.2, 129.01, 128.95, 128.75, 128.70, 128.5, 128.2, 127.0, 116.9, 82.2,
G
J. Org. Chem. XXXX, XXX, XXX−XXX